Researchers review how combining metal nanoparticles made using plant extracts with plant-derived compounds (like galantamine from snowdrops) could offer more effective treatments for Alzheimer's disease by blocking the enzyme that breaks down a key memory-related brain chemical.
1
Only one of the three FDA-approved Alzheimer's drugs (galantamine) is a naturally occurring plant alkaloid, derived from species including snowdrops (Galanthus) and daffodils (Narcissus).
2
Green synthesis uses plant-derived compounds to produce metal nanoparticles, combining the particles' physical properties with the therapeutic activity of the plant metabolites in a single agent.
3
The review identifies synergistic potential between metal nanoparticles and plant metabolites as a promising frontier, though no clinical trials are yet reported — findings remain at the research and review stage.
mail
Weekly plant science — one email, Saturdays.
Check your inbox to confirm — link expires in 24 hours.
Something went wrong — please try again.
Too many signup attempts from your network. Try again in an hour, or email hello@plant.news.
